M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response

M1 Macrophage Derived Exosomes Aggravate Experimental Autoimmune Neuritis via Modulating Th1 Response

Guillain–Barré syndrome (GBS), an immune-mediated disorder affecting the peripheral nervous system, is the most common and severe acute paralytic neuropathy. GBS remains to be potentially life-threatening and disabling despite the increasing availability of current standard therapeutic regimens. The...

Full description

Bibliographic Details
Main Authors:	Tong Du, Chun-Lin Yang, Meng-Ru Ge, Ying Liu, Peng Zhang, Heng Li, Xiao-Li Li, Tao Li, Yu-Dong Liu, Ying-Chun Dou, Bing Yang, Rui-Sheng Duan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Immunology
Subjects:	macrophages exosomes T helper 1 (Th1) cells IFN-γ experimental autoimmune neuritis (EAN) Guillain–Barré syndrome (GBS)
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01603/full

Similar Items

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats
by: Jeremias Motte, et al.
Published: (2018-04-01)

Peran Heat Shock Protein 47 sebagai Faktor Prediktor PrognosisExperimental Autoimmune Neuritis Studi eksperimental untuk mempelajari perjalanan penyakit Sindrom Guillain Barre menggunakan mencit Mus musculus Balb/C
by: Ruslan Muhyi
Published: (2016-11-01)

Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis
by: Anne K. Mausberg, et al.
Published: (2018-08-01)

CCR5 deficiency does not prevent P0 peptide 180–199 immunized mice from experimental autoimmune neuritis
by: Rui-Sheng Duan, et al.
Published: (2004-08-01)

Blocking Thrombin Significantly Ameliorates Experimental Autoimmune Neuritis
by: Efrat Shavit-Stein, et al.
Published: (2019-01-01)

Ginsenoside Rd attenuates mouse experimental autoimmune neuritis by modulating monocyte subsets conversion
by: Kaixi Ren, et al.
Published: (2021-06-01)

Guillain-Barré syndrome: celebrating a century
by: Marcos R. G. de Freitas, et al.

Hypokalaemic Periodic Paralysis– A Prospective Study of the Underlying Etiologies
by: Surya Narayana Jandhyala, et al.
Published: (2015-09-01)

The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain–Barré syndrome
by: Jiao H, et al.
Published: (2018-11-01)

Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway
by: Lu Xu, et al.
Published: (2019-04-01)

Guillain-Barre Syndrome Following Surgery
by: F Noorani, et al.
Published: (2007-04-01)

Outcome of Guillain - Barré Syndrome in Children: A prospective cohort study in a tertiary hospital in Upper Egypt
by: Abdelrahim Abdrabou Sadek, et al.
Published: (2016-12-01)

A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination
by: Yash Kripalani, et al.
Published: (2021-09-01)

Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
by: Björn Ambrosius, et al.
Published: (2017-04-01)

Surgery and Guillain-Barré Syndrome: A Single-Center Retrospective Study Focused on Clinical and Electrophysiological Subtypes
by: Bao L, et al.
Published: (2020-04-01)

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis
by: Lei Bao, et al.
Published: (2003-02-01)

Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome
by: Nandagopal Nithyashree, et al.
Published: (2014-01-01)

Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report
by: Achyut Sharma, et al.
Published: (2018-09-01)

Bilateral Facial Spasm Following Guillain–Barré Syndrome
by: Zain Guduru, et al.
Published: (2018-04-01)

Guillain-Barre syndrome after coronary artery bypass graft surgery: a case report and literature review
by: Sajid Hameed, et al.
Published: (2021-04-01)

The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System
by: Kathleen M. Hagen, et al.
Published: (2021-01-01)

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis
by: Kalliopi Pitarokoili, et al.
Published: (2019-09-01)

GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome – A case report, systemic review and implication for vaccine development
by: Catherine Dufour, et al.
Published: (2021-03-01)

Ventilator-Associated Pneumonia (VAP) in a Patient with Guillain-Barre Syndrome
by: Anti Dharmayanti, et al.
Published: (2017-04-01)

Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018
by: Ana Freitas Ribeiro, et al.
Published: (2021-06-01)

B cells play a cooperative role via CD40L–CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats
by: Wei Zhu, et al.
Published: (2007-03-01)

Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report
by: Vasileios G. Peponis, et al.
Published: (2012-10-01)

Efeito da administração do G-CSF nos mecanismos efetores e imunorreguladores na neurite experimental autoimune induzida em ratos Lewis = Effect of the administration of the G-CSF onto the effector and immuneregulatory mechanisms of the experimental autoimmune neuritis induced in Lewis rats
by: Pradella, Fernando, 1987-
Published: (2013)

Consecutive Eyeball Pressure Tests Reflect Clinically Relevant Vagal Dysfunction and Recovery in a Patient With Guillain-Barré-Syndrome With Tenacious Cardiac Dysautonomia
by: Anouck Becker, et al.
Published: (2020-09-01)

Is Guillain–Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence
by: Auwal Abdullahi, et al.
Published: (2021-01-01)

MANAGEMENT OF A GUILLAIN BARRE SYNDROME PATIENT THROUGH THREE TRACK REASONING: A CASE STUDY
by: Shamima Islam Nipa, et al.
Published: (2015-12-01)

Risk of Guillain-Barre Syndrome and H1N1 Influenza Vaccination
by: J Gordon Millichap
Published: (2012-08-01)

The Ten Years Survey on Clinical and Epidemiologic Features of Guillain-Barre Syndrome in Sina Hospital, Hamadan, Iran
by: Shahir Mazaheri, et al.
Published: (2007-09-01)

Clinical features and treatment of acute motor axonal neuropathy
by: Jie-ying LI, et al.
Published: (2015-12-01)

Guillain–Barre syndrome outbreak in Peru: Association with polymorphisms in IL‐17, ICAM1, and CD1
by: Luis Jaramillo‐Valverde, et al.
Published: (2019-10-01)

Enhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis
by: Ru-Tao Liu, et al.
Published: (2018-02-01)

Mitochondrial damage and “plugging” of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation
by: Marija Sajic, et al.
Published: (2018-02-01)

Progress in pathogenesis of Guillain⁃Barré syndrome
by: Jing ZHANG, et al.
Published: (2012-04-01)

Whole Genome Sequencing and Multiplex qPCR Methods to Identify Campylobacter jejuni Encoding cst-II or cst-III Sialyltransferase
by: Jason M. Neal-McKinney, et al.
Published: (2018-03-01)

Antibodies to ganglioside GM1 and Campylobacter jejuni in patients with Guillain-Barre syndrome
by: Basta Ivana, et al.
Published: (2005-01-01)